Cargando…

Evaluating the implications of Brexit for research collaboration and policy: a network analysis and simulation study

OBJECTIVE: To evaluate the role of the European Union (EU) as a research collaborator in the UK’s success as a global leader in healthcare research and innovation and quantify the impact that Brexit may have. DESIGN: Network and regression analysis of scientific collaboration, followed by simulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Garas, George, Cingolani, Isabella, Patel, Vanash M, Panzarasa, Pietro, Darzi, Ara, Athanasiou, Thanos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747879/
https://www.ncbi.nlm.nih.gov/pubmed/31506256
http://dx.doi.org/10.1136/bmjopen-2018-025025
_version_ 1783451996894789632
author Garas, George
Cingolani, Isabella
Patel, Vanash M
Panzarasa, Pietro
Darzi, Ara
Athanasiou, Thanos
author_facet Garas, George
Cingolani, Isabella
Patel, Vanash M
Panzarasa, Pietro
Darzi, Ara
Athanasiou, Thanos
author_sort Garas, George
collection PubMed
description OBJECTIVE: To evaluate the role of the European Union (EU) as a research collaborator in the UK’s success as a global leader in healthcare research and innovation and quantify the impact that Brexit may have. DESIGN: Network and regression analysis of scientific collaboration, followed by simulation models based on alternative scenarios. SETTING: International real-world collaboration network among all countries involved in robotic surgical research and innovation. PARTICIPANTS: 772 organisations from industry and academia nested within 56 countries and connected through 2397 collaboration links. MAIN OUTCOME MEASURES: Research impact measured through citations and innovation value measured through the innovation index. RESULTS: Globally, the UK ranks third in robotic surgical innovation, and the EU constitutes its prime collaborator. Brokerage opportunities and collaborators’ geographical diversity are associated with a country’s research impact (c=211.320 and 244.527, respectively; p<0·01) and innovation (c=18.819 and 30.850, respectively; p<0·01). Replacing EU collaborators with US ones is the only strategy that could benefit the UK, but on the condition that US collaborators are chosen among the top-performing ones, which is likely to be very difficult and costly, at least in the short term. CONCLUSIONS: This study suggests what has long been argued, namely that the UK-EU research partnership has been mutually beneficial and that its continuation represents the best possible outcome for both negotiating parties. However, the uncertainties raised by Brexit necessitate looking beyond the EU for potential research partners. In the short term, the UK’s best strategy might be to try and maintain its academic links with the EU. In the longer term, strategic relationships with research powerhouses, including the USA, China and India, are likely to be crucial for the UK to remain a global innovation leader.
format Online
Article
Text
id pubmed-6747879
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67478792019-09-27 Evaluating the implications of Brexit for research collaboration and policy: a network analysis and simulation study Garas, George Cingolani, Isabella Patel, Vanash M Panzarasa, Pietro Darzi, Ara Athanasiou, Thanos BMJ Open Health Policy OBJECTIVE: To evaluate the role of the European Union (EU) as a research collaborator in the UK’s success as a global leader in healthcare research and innovation and quantify the impact that Brexit may have. DESIGN: Network and regression analysis of scientific collaboration, followed by simulation models based on alternative scenarios. SETTING: International real-world collaboration network among all countries involved in robotic surgical research and innovation. PARTICIPANTS: 772 organisations from industry and academia nested within 56 countries and connected through 2397 collaboration links. MAIN OUTCOME MEASURES: Research impact measured through citations and innovation value measured through the innovation index. RESULTS: Globally, the UK ranks third in robotic surgical innovation, and the EU constitutes its prime collaborator. Brokerage opportunities and collaborators’ geographical diversity are associated with a country’s research impact (c=211.320 and 244.527, respectively; p<0·01) and innovation (c=18.819 and 30.850, respectively; p<0·01). Replacing EU collaborators with US ones is the only strategy that could benefit the UK, but on the condition that US collaborators are chosen among the top-performing ones, which is likely to be very difficult and costly, at least in the short term. CONCLUSIONS: This study suggests what has long been argued, namely that the UK-EU research partnership has been mutually beneficial and that its continuation represents the best possible outcome for both negotiating parties. However, the uncertainties raised by Brexit necessitate looking beyond the EU for potential research partners. In the short term, the UK’s best strategy might be to try and maintain its academic links with the EU. In the longer term, strategic relationships with research powerhouses, including the USA, China and India, are likely to be crucial for the UK to remain a global innovation leader. BMJ Publishing Group 2019-09-10 /pmc/articles/PMC6747879/ /pubmed/31506256 http://dx.doi.org/10.1136/bmjopen-2018-025025 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Health Policy
Garas, George
Cingolani, Isabella
Patel, Vanash M
Panzarasa, Pietro
Darzi, Ara
Athanasiou, Thanos
Evaluating the implications of Brexit for research collaboration and policy: a network analysis and simulation study
title Evaluating the implications of Brexit for research collaboration and policy: a network analysis and simulation study
title_full Evaluating the implications of Brexit for research collaboration and policy: a network analysis and simulation study
title_fullStr Evaluating the implications of Brexit for research collaboration and policy: a network analysis and simulation study
title_full_unstemmed Evaluating the implications of Brexit for research collaboration and policy: a network analysis and simulation study
title_short Evaluating the implications of Brexit for research collaboration and policy: a network analysis and simulation study
title_sort evaluating the implications of brexit for research collaboration and policy: a network analysis and simulation study
topic Health Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747879/
https://www.ncbi.nlm.nih.gov/pubmed/31506256
http://dx.doi.org/10.1136/bmjopen-2018-025025
work_keys_str_mv AT garasgeorge evaluatingtheimplicationsofbrexitforresearchcollaborationandpolicyanetworkanalysisandsimulationstudy
AT cingolaniisabella evaluatingtheimplicationsofbrexitforresearchcollaborationandpolicyanetworkanalysisandsimulationstudy
AT patelvanashm evaluatingtheimplicationsofbrexitforresearchcollaborationandpolicyanetworkanalysisandsimulationstudy
AT panzarasapietro evaluatingtheimplicationsofbrexitforresearchcollaborationandpolicyanetworkanalysisandsimulationstudy
AT darziara evaluatingtheimplicationsofbrexitforresearchcollaborationandpolicyanetworkanalysisandsimulationstudy
AT athanasiouthanos evaluatingtheimplicationsofbrexitforresearchcollaborationandpolicyanetworkanalysisandsimulationstudy